Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Reflectance confocal microscopy confirms that yellow dots are signs of damaged hair follicles in alopecia areata.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Obesity and lifestyle strongly affect heart aging.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Oral steroids may effectively treat recurrent intussusception in children with ILH, possibly avoiding surgery.

New techniques for treating scalp blood vessel malformations are effective and can have good cosmetic results.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

Applying a special DNA plasmid to the skin can make it thicker and stronger.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

A woman developed male traits from accidental contact with her husband's testosterone gel.

Hair follicle regeneration may slow tumor growth.

Researchers developed a nanomedicine for acne treatment that delivers medication with less irritation and is non-irritating for oily skin.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Different factors like pH, gel type, and chemical enhancers affect how well hydrocortisone gets into hair follicles, and less hydrated skin doesn't work well with the test method.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Increasing PBX1 reduces aging and cell death in hair follicle stem cells by boosting SIRT1 and lowering PARP1 activity.